Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1678
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2498
    -0.0013 (-0.10%)
     
  • Bitcoin GBP

    51,224.88
    -421.71 (-0.82%)
     
  • CMC Crypto 200

    1,332.28
    -64.26 (-4.60%)
     
  • S&P 500

    5,104.73
    +56.31 (+1.12%)
     
  • DOW

    38,290.75
    +204.95 (+0.54%)
     
  • CRUDE OIL

    83.73
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,351.50
    +9.00 (+0.38%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

AstraZeneca, Lilly Join Others On Failed Alzheimer's Drug Heap

AstraZeneca, Lilly Join Others On Failed Alzheimer's Drug Heap

AstraZeneca and Eli Lilly became the latest Tuesday in a series of firms to scrap studies of a potential Alzheimer's disease treatment that appeared unlikely to work.